The Impact Seat

The firm's advisory practice—which consults corporations on diversity, equity, and inclusion (DEI) strategy—functions as a proprietary sourcing channel. Corporate clients often surface market gaps or emerging brands that align with inclusive procurement goals, giving the investment team early visibility into companies that might otherwise remain outside typical venture networks. This dual structure reduces reliance on blind inbound deal flow.

It operates as both, which is unusual. The investment arm makes direct equity investments in early-stage companies, while the advisory arm generates revenue through corporate DEI consulting engagements. The two sides are commercially linked: advisory relationships inform investment theses, and portfolio companies can become vendor recommendations for corporate clients.

The firm targets early-stage, for-profit startups where women or people of color hold meaningful ownership or leadership positions. Sector activity includes health and wellness, education technology, and consumer goods—industries where demographic shifts in purchasing power create structural demand tailwinds. Stage preference runs from seed through Series A.

Capital deployment is structured around direct equity investments rather than commitments to external funds. The firm has not publicly indicated a fund-of-funds program or participation in manager-selection mandates. This keeps the investment team directly engaged with portfolio company operations.

The firm has not publicized an AUM figure through its own website, regulatory filings, or major financial press. Given its small scale and hybrid operating model—where advisory income supplements investment returns—standard venture capital AUM comparisons are less meaningful. The firm's posture suggests capital is raised on a deal-by-deal basis or through a single family office backing that has not been publicly identified (Altss estimate).